Maxim Group Downgrades Guardion Health Sciences to Hold
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Anthony Vendetti downgraded Guardion Health Sciences (GHSI) from Buy to Hold, indicating a more cautious outlook on the company's stock.
February 02, 2024 | 11:19 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Guardion Health Sciences was downgraded from Buy to Hold by Maxim Group analyst Anthony Vendetti, suggesting a neutral short-term outlook.
The downgrade from Buy to Hold by a prominent analyst suggests a shift to a more cautious stance on GHSI's stock. This could lead to a neutral impact on the stock price in the short term as investors reassess their positions based on this new analyst rating.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90